Academics
follow us
  • Linkedin
  • Twitter
  • Facebook
  • Youtube
  • Instagram
Feedback
Patent Number:- IN364102

A Hydrophilic Redox-Responsive Polymeric Micelle Comprising Chlorin E6 for Photodynamic Therapy

  • Sector: Biomedical Engineering,
  • IPC: C12M,
 

Need

Existing methods lack efficient delivery of Chlorin e6 (Ce6) to target cancer cells due to poor solubility, hindering effective treatment.

Solution

The invention proposes a polymeric micelle formulation of mPEG-PLA-S-S-Ce6, enhancing solubility and enabling targeted drug release in tumors.

Innovation

Development of a method for producing mPEG-PLA-S-S-Ce6 micelles, incorporating a redox-responsive polymeric micelle for enhanced photodynamic therapy of cancer cells.

Market Analysis

Market: Cancer Treatment, Pharmaceutical Delivery Systems

CAGR: High, driven by advances in targeted cancer therapies

Potential Indian Clients: Oncology centers, pharmaceutical manufacturers specializing in cancer therapy

Why Invest?


Photodynamic therapy

Redox-responsive

Methoxy poly(ethylene glycol)-poly(lactic acid) copolymer

Tumors

At a Glance


Current TRL: NA

Funded by: NA

IPC: C12M

Domain: Biomedical Engineering, Photodynamic Therapy

For more information, reach out to Mr. Rajneesh Kumar, Head of the Technology Transfer Office, at tto@bits-pilani.ac.in and 01596-255515.